Northwire Canada EditionFriday, July 17, 2026
Sign inSubscribe
Northwire
⌕
FL 0.405 −1.2% SSRM 35.29 −2.9% CD 0.230 +0.0% GEN 0.070 +0.0% ALS 55.11 −4.1% WGX 4.23 −4.5% LIFT 3.06 −2.9% NTR 94.63 +0.4% ICON 0.045 +0.0% LMG 0.450 +0.0% NZP 0.045 −10.0% RJX 0.030 +0.0% PRU 4.54 −2.2% MOO 0.720 +0.0% BSX 0.810 −14.7% SLI 2.96 −3.9% FL 0.405 −1.2% SSRM 35.29 −2.9% CD 0.230 +0.0% GEN 0.070 +0.0% ALS 55.11 −4.1% WGX 4.23 −4.5% LIFT 3.06 −2.9% NTR 94.63 +0.4% ICON 0.045 +0.0% LMG 0.450 +0.0% NZP 0.045 −10.0% RJX 0.030 +0.0% PRU 4.54 −2.2% MOO 0.720 +0.0% BSX 0.810 −14.7% SLI 2.96 −3.9%

Healthcare

Page 101
  1. Nov 17, 2025 · 16:31 · AGN

    Algernon signs contract, investment deal with AMI

    Algernon signs contract, investment deal with AMI

    01
  2. Nov 17, 2025 · 16:25 · TLT

    Theralase to host conference call Nov. 19

    Theralase to host conference call Nov. 19

    02
  3. Nov 17, 2025 · 16:15 · FRX

    Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

    Fennec Pharmaceuticals Announces Closing of Offering of Common Shares

    03
  4. Nov 17, 2025 · 13:45 · KDA

    KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION

    KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION

    04
  5. Nov 17, 2025 · 09:43 · SEGN

    SEEGNAL INC. ANNOUNCES THE APPOINTMENT OF ELAD BIBI-AVIV AS NEW CHIEF EXECUTIVE OFFICER

    SEEGNAL INC. ANNOUNCES THE APPOINTMENT OF ELAD BIBI-AVIV AS NEW CHIEF EXECUTIVE OFFICER

    05
  6. Nov 17, 2025 · 08:31 · MDP

    Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares

    Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares

    06
  7. Nov 17, 2025 · 08:01 · PHRM

    PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program

    PharmaTher Advances Strategy to Build Next-Generation Ketamine Franchise for Neuropsychiatric Disorders; Secures Exclusive Rights to Evaluate and License Patented Long-Acting Ketamine Program

    07
  8. Nov 17, 2025 · 08:00 · PINK

    HCA HealthONE Rose First in Colorado to Adopt Perimeter's Advanced OCT Imaging Technology for Use in Surgery

    HCA HealthONE Rose First in Colorado to Adopt Perimeter's Advanced OCT Imaging Technology for Use in Surgery

    08
  9. Nov 17, 2025 · 07:02 · TLT

    Theralase(R) Investor Conference Call Reminder

    Theralase(R) Investor Conference Call Reminder

    09
  10. Nov 17, 2025 · 07:00 · AGN

    Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

    Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement

    10
  11. Nov 17, 2025 · 06:50 · DRUG

    Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

    Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS)

    11
  12. Nov 17, 2025 · 02:01 · 4565

    Nxera Announces Focused Restructuring to Enhance Path to Profitability

    Nxera Announces Focused Restructuring to Enhance Path to Profitability

    12
  13. Nov 14, 2025 · 20:03 · AGN

    Algernon closes $177,000 first tranche of financing

    Algernon closes $177,000 first tranche of financing

    13
  14. Nov 14, 2025 · 19:55 · AGN

    Algernon Closes First Tranche of its Recently Announced Private Placement Financing

    Algernon Closes First Tranche of its Recently Announced Private Placement Financing

    14
← Newer Older →